Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.
Journal: Science (New York, N.Y.)
Published: July 16, 2026
A Dermatologist's Perspective on Cutaneous Adverse Effects in CTCAE Version 6.0.
Journal: JAMA oncology
Published: May 21, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse Events-Reply.
Journal: JAMA oncology
Published: May 07, 2026
Expert opinion on burning questions in cancer myeloid cell biology.
Journal: Journal for immunotherapy of cancer
Published: May 04, 2026
Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2026
Author Correction: Innovative approaches for lung cancer screening and interception.
Journal: Nature reviews. Clinical oncology
Published: March 11, 2026
Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer.
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Innovative approaches for lung cancer screening and interception.
Journal: Nature reviews. Clinical oncology
Published: February 06, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical Trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 26, 2026
Morbidity and Mortality Outcomes of Dupilumab for Cutaneous Immune-Related Adverse Events.
Journal: JAMA oncology
Published: January 22, 2026
Last Updated: 09/26/2026